nach oben

Clinical Oral Investigations

Erschienen in:

25.06.2018 | Original Article

Metabolomics profiling of cleidocranial dysplasia

verfasst von: Zhaoqiang Zhang, Kefeng Li, Mengdie Yan, Qiuping Lin, Jiahong Lv, Ping Zhu, Yue Xu

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Cleidocranial dysplasia (CCD) is a rare autosomal-dominantly inherited skeletal dysplasia that is predominantly associated with heterozygous mutations of RUNX2. However, no information is available regarding metabolic changes associated with CCD at present.

Materials and methods

We analyzed members of a CCD family and checked for mutations in the RUNX2 coding sequence using the nucleotide BLAST program. The 3D protein structure of mutant RUNX2 was predicted by I-TASSER. Finally, we analyzed metabolites extracted from plasma using LC-MS/MS.

Results

We identified a novel mutation (c.1061insT) that generates a premature termination in the RUNX2 coding region, which, based on protein structure prediction models, likely alters the protein’s function. Interestingly, metabolomics profiling indicated that 30 metabolites belonging to 13 metabolic pathways were significantly changed in the CCD patients compared to normal controls.

Conclusions

The results highlight interesting correlations between a RUNX2 mutation, metabolic changes, and the clinical features in a family with CCD. The results also contribute to our understanding of the pathogenetic processes underlying this rare disorder.

Clinical relevance

This study provides the first metabolomics profiling in CCD patients, expands our insights into the pathogenesis of the disorder, may help in diagnostics and its refinements, and may lead to novel therapeutic approaches to CCD.

Cooper SC, Flaitz CM, Johnston DA, Lee B, Hecht JT (2001) A natural history of cleidocranial dysplasia. Am J Med Genet 104(1):1–6CrossRefPubMed

Mundlos S (1999) Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet 36(3):177–182PubMedPubMedCentral

Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89(5):773–779CrossRefPubMed

Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Hecht J, Geoffroy V, Ducy P, Karsenty G (1997) Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 16(3):307–310CrossRefPubMed

Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1, a transcriptional activator of osteoblast differentiation. Cell 89(5):747–754CrossRefPubMed

Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K, Yamana K, Zanma A, Takada K, Ito Y, Komori T (2004) Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18(8):952–963CrossRefPubMedPubMedCentral

Li Y, Xiao Z (2007) Advances in Runx2 regulation and its isoforms. Med Hypotheses 68(1):169–175CrossRefPubMed

Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, Karsenty G (1998) Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ. Mol Cell Biol 18(7):4197–4208CrossRefPubMedPubMedCentral

Zhang YW, Yasui N, Ito K, Huang G, Fujii M, Hanai J, Nogami H, Ochi T, Miyazono K, Ito Y (2000) A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci U S A 97(19):10549–10554CrossRefPubMedPubMedCentral

10.

Afzal F, Pratap J, Ito K, Ito Y, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Javed A (2005) Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol 204(1):63–72CrossRefPubMed

11.

Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR (2001) Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106(1–2):97–106CrossRefPubMed

12.

Zaidi SK, Pande S, Pratap J, Gaur T, Grigoriu S, Ali SA, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2007) Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc Natl Acad Sci U S A 104(50):19861–19866CrossRefPubMedPubMedCentral

13.

Mak IW, Cowan RW, Popovic S, Colterjohn N, Singh G, Ghert M (2009) Upregulation of MMP-13 via Runx2 in the stromal cell of giant cell tumor of bone. Bone 45(2):377–386CrossRefPubMed

14.

Teplyuk NM, Zhang Y, Lou Y, Hawse JR, Hassan MQ, Teplyuk VI, Pratap J, Galindo M, Stein JL, Stein GS, Lian JB, van Wijnen AJ (2009) The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol 23(6):849–861CrossRefPubMedPubMedCentral

15.

Sawai CM, Sisirak V, Ghosh HS, Hou EZ, Ceribelli M, Staudt LM, Reizis B (2013) Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J Exp Med 210(11):2151–2159CrossRefPubMedPubMedCentral

16.

Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javed A, Zaidi SK, Young DW, Choi JY, Pockwinse SM (2004) Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 23(24):4315–4329CrossRefPubMed

17.

Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC (2000) Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20(23):8783–8792CrossRefPubMedPubMedCentral

18.

Putri SP, Nakayama Y, Matsuda F, Uchikata T, Kobayashi S, Matsubara A, Fukusaki E (2013) Current metabolomics, practical applications. J Biosci Bioeng 115(6):579–589CrossRefPubMed

19.

Yuan M, Breitkopf SB, Yang X, Asara JM (2012) A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 7(5):872–881CrossRefPubMedPubMedCentral

20.

Zhang C, Zheng S, Wang Y, Zhao Y, Zhu J, Ge L (2010) Mutational analysis of RUNX2 gene in Chinese patients with cleidocranial dysplasia. Mutagenesis 25(6):589–594CrossRefPubMed

21.

Wang S, Zhang S, Wang Y, Chen Y, Zhou L (2013) Cleidocranial dysplasia syndrome, clinical characteristics and mutation study of a Chinese family. Int J Clin Exp Med 6(10):900–907PubMedPubMedCentral

22.

Otto F, Kanegane H, Mundlos S (2002) Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum Mutat 19(1):209–216CrossRefPubMed

23.

Ott CE, Leschik G, Trotier F, Brueton L, Brunner HG, Brussel W, Guillen-Navarro E, Haase C, Kohlhase J, Kotzot D, Lane A, Lee-Kirsch MA, Morlot S, Simon ME, Steichen-Gersdorf E, Tegay DH, Peters H, Mundlos S, Klopocki E (2010) Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum Mutat 31(8):15871593CrossRef

24.

Baumert U, Golan I, Redlich M, Aknin JJ, Muessig D (2005) Cleidocranial dysplasia, molecular genetic analysis and phenotypic-based description of a middle European patient group. Am J Med Genet 139((2):78–85CrossRef

25.

Bufalino A, Paranaíba LM, Gouvêa AF, Gueiros LA, Martelli-Júnior H, Junior JJ, Lopes MA, Graner E, De Almeida OP, Vargas PA, Coletta RD (2012) Cleidocranial dysplasia, oral features and genetic analysis of 11 patients. Oral Dis 18(2):184–190CrossRefPubMed

26.

Singh A, Goswami M, Pradhan G, Han MS, Choi JY, Kapoor S (2015) Cleidocranial dysplasia with normal clavicles, a report of a novel genotype and a review of seven previous cases. Mol Syndromol 6(2):83–86CrossRefPubMedPubMedCentral

27.

Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics—a review in human disease diagnosis. Anal Chim Acta 659(1–2):23–33CrossRefPubMed

28.

Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella M (1998) Reduction in transforming growth factor b receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid. J Biol Chem 273(9):4892–4896CrossRefPubMed

29.

Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, Mav D, Kohn-Gabet AE, Shi Y, Coetzee GA, Frenkel B (2010) Runx2 transcriptome of prostate cancer cells, insights into invasiveness and bone metastasis. Mol Cancer 9:258CrossRefPubMedPubMedCentral

30.

Kilbey A, Terry A, Jenkins A, Borland G, Zhang Q, Wakelam MJ, Cameron ER, Neil JC (2010) Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res 70(14):5860–5869CrossRefPubMedPubMedCentral

31.

Choe M, Brusgard JL, Chumsri S, Bhandary L, Zhao XF, Lu S, Goloubeva OG, Polster BM, Fiskum GM, Girnun GD, Kim MS, Passaniti A (2015) The RUNX2 transcription factor negatively regulates SIRT6 expression to Alter glucose metabolism in breast Cancer cells. J Cell Biochem 116(10):2210–2226CrossRefPubMedPubMedCentral

32.

Adhami M, Ghori-Javed FY, Chen H, Gutierrez SE, Javed A (2011) Runx2 regulates the gene network associated with insulin signaling and energy homeostasis. Cells Tissues Organs 194(2–4):232–237CrossRefPubMedPubMedCentral

Titel: Metabolomics profiling of cleidocranial dysplasia
verfasst von: Zhaoqiang Zhang
Kefeng Li
Mengdie Yan
Qiuping Lin
Jiahong Lv
Ping Zhu
Yue Xu
Publikationsdatum: 25.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 3/2019
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-018-2496-9

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Salivary levels and immunohistochemical expression of selected angiogenic factors in benign and malignant parotid gland tumours

Is the pneumatisation of the maxillary sinus following tooth loss a reality? A retrospective analysis using cone beam computed tomography and a customised software program

Effectiveness of adjunctive hyaluronic acid application in coronally advanced flap in Miller class I single gingival recession sites: a randomized controlled clinical trial

Response to: “Direct oral anticoagulants, vitamin K antagonists and simple single tooth extraction”

Oral findings in children and adolescents with Prader-Willi syndrome

Carotid calcifications in panoramic radiographs are associated with future stroke or ischemic heart diseases: a long-term follow-up study

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter